Metal binding by pharmaceuticals. part 2. interactions of Ca(II), Cu(II), Fe(II), Mg(II), Mn(II) and Zn(II) with the intracellular hydrolysis products of the antitumour agent ICRF 159 and its inactive homologue ICRF 192-Reference-Cited by-同舟云学术

Metal binding by pharmaceuticals. part 2. interactions of Ca(II), Cu(II), Fe(II), Mg(II), Mn(II) and Zn(II) with the intracellular hydrolysis products of the antitumour agent ICRF 159 and its inactive homologue ICRF 192

Published:1982-04 Issue:4 Volume:12 Page:536-542
ISSN:0065-4299
Container-title:Agents and Actions
language:en
Short-container-title:Agents and Actions

Author:

Huang Zhong-Xian,May Peter M.,Quinlan Kevin M.,Williams David R.,Creighton Andrew M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Toxicology,Pharmacology,Immunology

Link

http://link.springer.com/content/pdf/10.1007/BF01965940.pdf

Reference32 articles.

1. A. Cole, P.M. May andD.R. Williams,Metal binding by pharmaceuticals, Part 1. Copper(II) and zinc(II) interactions following ethambutol administration, Agents and Actions11, 296–305 (1981).

2. A.M. Creighton, K. Hellmann andS. Whitecross,Antitumour activity in a series of bisdiketopiperazines, Nature222, 384–385 (1969).

3. K. Hellmann andK. Burrage,Control of metastases by ICRF 159, Nature224, 273–275 (1969).

4. A.J. Salsbury, K. Burrage andK. Hellmann,Inhibition of metastatic spread by ICRF 159: Selective deletion of a malignant characteristic, Br. Med. J.4, 344–346 (1970).

5. A.J. Salsbury, K. Burrage andK. Hellman,Histological analysis of the antimetastatic effect of (±)-1,2-bis(3,5-dioxopiperazin-1-yl) propane, Cancer Res.34, 843–849 (1974).

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure–Activity Relationship Study of Dexrazoxane Analogues Reveals ICRF-193 as the Most Potent Bisdioxopiperazine against Anthracycline Toxicity to Cardiomyocytes Due to Its Strong Topoisomerase IIβ Interactions;Journal of Medicinal Chemistry;2021-03-22

2. Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection;Antioxidants & Redox Signaling;2013-03-10

3. Dexrazoxane provided moderate protection in a catecholamine model of severe cardiotoxicity;Canadian Journal of Physiology and Pharmacology;2012-04

4. Dexrazoxane;Razoxane and Dexrazoxane - Two Multifunctional Agents;2010

5. Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane;British Journal of Cancer;2009-09